Gilead
Gilead set to acquire Arresto for $225 million
December 23, 2010Research and Development AB0024, Arresto, Cancer, Gilead, advanced solid tumours, ambrisentan, fibrotic diseases, idiopathic pulmonary fibrosis
Gilead Sciences is set to acquire fellow California, US-based biotech Arresto for $225 million to bolster its early stage pipeline. …
Gilead’s pill shows promise in HIV prevention
November 25, 2010Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir
Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
FDA warns Gilead over contamination risks at California facility
October 25, 2010Manufacturing and Production AmBisome, Cayston, FDA, Gilead, Macugen, Viread, manufacturing compliance, pharma manufacturing
Gilead Sciences has been sent a warning letter from the FDA after failing to rectify problems at a facility used to …
Gilead is latest drugmaker in FDA’s sights
August 13, 2010Manufacturing and Production Gilead, cystic fibrosis, manufacturing compliance
A manufacturing and distribution facility operated by US biotech Gilead Sciences is at risk of receiving a warning letter from …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
August 14, 2026
